Healthcare law organization Frier Levitt has analyzed FDA enforcement steps towards “investigate only” peptide distributors. Their conclusion: the FDA considers a product’s classification according to its supposed use, not its disclaimers. When Internet sites involve dosage guides, reconstitution Directions, or website link to message boards